biliary tract disease
DESCRIPTION
Dr Julia Epstein Gastroenterology department Hadassah Medical center. Biliary Tract Disease. Biliary disease. Gallstones Congenital anomalies Extrinsic compression of the bile ducts Hepatobiliary parasitism Noncancerous strictures. Biliary tract anatomy. Ampullary anatomy. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/1.jpg)
BILIARY TRACT DISEASEDr Julia EpsteinGastroenterology departmentHadassah Medical center
![Page 2: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/2.jpg)
Biliary disease
• Gallstones • Congenital anomalies• Extrinsic compression of the bile ducts• Hepatobiliary parasitism• Noncancerous strictures
![Page 3: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/3.jpg)
Biliary tract anatomy
![Page 4: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/4.jpg)
Ampullary anatomy
Pancreatic duct sphincter
Biliary duct sphincter
Sphincter of Oddi
Papilla of Vater
![Page 5: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/5.jpg)
כיס מרה
ס"מ7.5-10מבנה אגסי • ס"מ30-50תכולה ••
מרה מיוצרת←כבד ••מרה נאגרת←כיס מרה ••
•CCK• אוכל שומני←תרסריון←הפרשת+ מרה מתכווץ
ספינקטר ע"ש אודי נפרה ← מעבר מיצי •מרה לתריסריון
ספיגה מחדש לוריד הפורטלי←חזרה ••לכבד Enterohepatic Circulation :
כבד←מרה←מעי
![Page 6: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/6.jpg)
מיצי מרה: מים, אלקטרוליטייםמכיל -
Na, K, Ca, Cl, HCO3 ,לציטין,חומצות שומן, כולסטרול
בילירובין ומלחי מרה
?מאיפה מגיע בילירובין:תפקיד
ספיגה של השומנים לאחר תהליך אמולסיפיקציה –
שפעול מיצי הלבלב –
המרה )בסיסית( סותרת את מיץ הקיבה החומצי –
.המגיע לתריסריון
![Page 7: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/7.jpg)
מבנה מרה
• מלחי המרה ← מסיסים במים
• פוספוליפידים + הכולסטרול ← לא מסיסים במים
• הופכים למסיסים שנוצרות מיצלות
• היחס בין שלושת המרכיבים עדין
• ← כל חריגה מהיחס המסוים
• מרה רוויה + שקיעה של
• כולסטרול )יצירת אבנים(
![Page 8: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/8.jpg)
![Page 9: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/9.jpg)
Principal pathways of cholesterol metabolism in liver
![Page 10: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/10.jpg)
Gallstones – Pathophysiology
• Cholesterol, ordinarily insoluble in water, comes into solution by forming vesicles with phospholipids
• If ratio of cholesterol, phospholipids, and bile salts altered, cholesterol crystals may form
• Gallstone formation involves a variety of factors:– Cholesterol supersaturation– Mucin hypersecretion by the gallbladder mucosa
creates a viscoelastic gel that fosters nucleation. – Bile stasis
![Page 11: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/11.jpg)
Gallstone pathogenesis
![Page 12: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/12.jpg)
Gallstones • Risk factors:• Obesity• Female gender • Parity• Maternal family history ( ABCB4 , CYP7A1)• Ethnic predilection (Hispanic, Native americans)• Increasing age• Rapid weight loss
![Page 13: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/13.jpg)
Gallstones
• Risk factors: Ileal diseaseLipid abnormalities (high TG, low LDL)Medications (contraceptives, postmenopausal estrogens, lipid lowering agents fibric acid derivated)• TPN
![Page 14: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/14.jpg)
5 F’s• Fair• Fat• Fertile• Female• Forty
![Page 15: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/15.jpg)
מצבים שכיחים
• Cholelithiasis• Biliary colic• Hydrops• Empyema• Choledocholithiasis• Acute Cholecystitis• Ascending Cholangitis
![Page 16: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/16.jpg)
Gallstones – Types
• Two main types:– Cholesterol stones (85%)– Pigment stones (15%) occur in 2 subtypes— brown and black.
• Black stones result when excess bilirubin enters the bile and polymerizes into calcium bilirubinate (chronic hemolysis)
• Brown stones are made up of calcium bilirubinate and calcium-soaps. Bacteria involved in formation via secretion of beta glucuronidase and phospholipase
![Page 17: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/17.jpg)
Gallstones – Natural History
• 80% of patients, gallstones are clinically silent
• 20% of patients develop symptoms over 15-20 years (1-2% per year)
• 50-70% continued to have symptoms and complications
• More than 90% of complications are preceded by biliary colic
![Page 18: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/18.jpg)
Biliary Colic
• Intermittent obstruction of the cystic duct, no inflammation of GB
• Severe epigastric/ RUQ pain growing over 15 min and remaining constant up to 3h
• Frequency of attacks varies• Normal examination• Lab tests usually normal• DS: US, EUS• Natural history: 30% have no further symptoms 50% continue symptoms in 2y
![Page 19: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/19.jpg)
![Page 20: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/20.jpg)
Acute Calculous Cholecystitis
• Impacted stone in the cystic duct• 75% are preceded by attacks of biliary colic• Visceral epigastric pain – mod to severe, irradiated to RUQ,
back, shoulder, chest and lasting > 6 h• Fever, Right subcostal tenderness with inspiratory arrest ( Murphy’s sign) , palpable GB• Leucocytosis, mild elevation of BIL, Amylase• 50% resolve spontaneously in 7-10 days without surgery• DS: US, EUS, CT• 10% are complicated by perforation.
![Page 21: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/21.jpg)
![Page 22: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/22.jpg)
Empyema / Mucocoele
• Mucocele refers to an overdistended gallbladder filled with mucoid or clear and watery content.
• Empyema refers to a gallbladder filled with pus due to acute cholecystitis
![Page 23: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/23.jpg)
Choledocholithiasis
• Intermittent obstruction of CBD• Often symptomatic – indistinguishable from biliary
colic• Predisposed to acute cholangitis and pancreatitis• Signs : jaundice with pain. • Investigations
– Elevated BIL, transient spike in Tranaaminases / Amylase, – US, EUS, CT
• Treatment – ERCP - Endoscopic Retrograde CholangioPancreatography
![Page 24: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/24.jpg)
![Page 25: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/25.jpg)
Ascending Cholangitis
• Impacted stone in CBD causing bile stasis•Bacterial superinfection•Charcot’s triad : pain, jaundice, fever – 70%•Mental confusion, hypotension, RUQ tenderness• Jaundice (>80%)•Peritoneal signs (15%)•Elevated WBC, BIL, APH (blood cult usually pos)•Emergent decompression of the CBD (ERCP, PTC)
![Page 26: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/26.jpg)
Acute biliary pancreatitis• Pancreatic duct obstruction or chemical inflammation • Signs - Variable – None to Sepsis
(Severe pain, fever, tachycardia, low BP), Jaundice, acute abdomen• Investigations
• Bloods – U&E, FBC, LFT, Amylase, CRP• Ultrasound of abdomen• MRCP• CT Pancreas
• Treatment Supportive / ERCP
![Page 27: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/27.jpg)
Gallstone ileus
• Obstruction of the small bowel by a large gallstone–A stone ulcerates through the gallbladder into the
duodenum and causes obstruction at the terminal ileum/rt colon
• Symptoms : SBO - vomiting, abdominal pain, distension, obstructive bowel sounds
• Investigations: X-ray, US/CT - air in CBD• Treatment : Laparotomy and removal of stone from
small bowel and cholecystectomy.
![Page 28: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/28.jpg)
Mirizzi’s Syndrome
Inflammatory phenomenon secondary to a pressure ulcer caused by an impacted gallstone at the gallbladder infundibulum
The impacted gallstone causes first external obstruction of the CBD
Eventually erodes into the bile duct evolving into a
cholecystocholedochal fistula with different degrees of communication between the GB and CBD
![Page 29: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/29.jpg)
Mirizzi’s Syndrome
![Page 30: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/30.jpg)
![Page 31: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/31.jpg)
Lemmmel’s Syndrome
Duodenal diverticula syndromeSecondary to extrinsic compression by
periampullary diverticula in the absence of additional pathology (cholelithiasis, tumor)
• The hypothesized mechanisms:• Alterations of the papillary motility• Bacterial contamination• Extrinsic compression of the Main biliary tract
![Page 32: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/32.jpg)
Lemmmel’s Syndrome
![Page 33: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/33.jpg)
Acute Acalculous Cholecystitis
• Presence of an inflamed gallbladder in the absence of an obstructed cystic or common bile duct
• Typically occurs in the setting of a critically ill patient (eg, severe burns, multiple traumas, lengthy postoperative care, prolonged intensive care)
• Accounts for 5% of cholecystectomies• Etiology is thought to have ischemic basis, and gangrenous
gallbladder may result• Increased rate of complications and mortality• An uncommon subtype known as acute emphysematous
cholecystitis generally is caused by infection with clostridial organisms and occlusion of the cystic artery associated with atherosclerotic vascular disease and, often, diabetes.
![Page 34: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/34.jpg)
Cholecystectomy
• Laparoscopic cholecystectomy standard of care
• Timing– Early vs interval operation
• Patient consent– Conversion to open
procedure 10%– Bleeding– Bile duct injury– Damage to other organs
![Page 35: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/35.jpg)
Biliary disease
• Gallstones • Congenital anomalies• Extrinsic compression of the bile ducts• Hepatobiliary parasitism• Noncancerous strictures
![Page 36: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/36.jpg)
Biliary Tract Cysts
• Choledochal cysts• Consist of cystic dilatations of the extra-
hepatic biliary tree• Uncommon abnormality and 90% diagnosed
before age 30• Infantile form presentation identical to biliary
atresia• 50% present with combination of jaundice,
abdominal pain, and an abdominal mass
![Page 37: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/37.jpg)
Choledochal cysts
• Classified into 5 types• Can occur in the presence of pancreatico-
biliary maljunction (PBM) • Treatment for choledochal cysts is surgical
excision of the cyst with construction• Most ominous complication is malignancy
![Page 38: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/38.jpg)
Choledochal cysts
Caroli disease
PBM
![Page 39: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/39.jpg)
Biliary ductopenic disorders
• Paucity of interlobular bile ducts - 2 types: syndromic and non syndromic
Syndromic ( Alagille’s syn) ADD d/t JAG1 gene Intrahepatic cholestasis and biliary hypoplasiaPruritus and hepatomegalyExtrahepatic manifeatations - congenital heartdefects, eye defects, triangular face
![Page 40: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/40.jpg)
Biliary ductopenic disorders
• interlobular ductopenia as result of inflammatory condition:
• PSC• PBC• GVHD• Liver allograft resection• Drug induced liver disease• idiopathic
![Page 41: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/41.jpg)
Biliary disease
• Gallstones • Congenital anomalies
• Extrinsic compression of the bile ducts• Hepatobiliary parasitism• Noncancerous strictures
![Page 42: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/42.jpg)
Extrinsic compression of the bile ducts
• Biliary tract tumor• Carcinoma of the head of pancreas• Acute and chronic pancreatitis• Lymph nodes – lymphoma or metastasis• Benign stricture of biliary ducts
![Page 43: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/43.jpg)
Biliary Tract Tumor Cholangiocarcinoma
Cancer of the Gall Bladder
![Page 44: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/44.jpg)
Cholangiocarcinoma
• Slow growing malignancy of biliary tract which tend to infiltrate locally and metastasize late
• 90% adenocarcinoma• 60-70% at the bifurcation ofhepatic ducts• 20-30% - in the distal CBD• 5-10% - arise within the liver (peripheral)
![Page 45: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/45.jpg)
Biliary Tree Neoplasms
• Clinical symptoms:– Weight loss (77%)– Nausea (60%)– Anorexia (56%)– Abdominal pain (56%)– Fatigue (63%)– Pruritus (51%)
• Symptomatic patients usually have advanced disease, with spread to hilar lymph nodes before obstructive jaundice occurs
• Associated with a poor prognosis
• Fever )21%(• Malaise )19%(• Diarrheoa )19%(• Constipation )16%(• Abdominal fullness )16%(.
![Page 46: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/46.jpg)
Risk factors
• Liver flukes (Opistorchis viverrini, Chlonorchis sinensis)
• Chemial exposition (Asbestosis)• Congenital predisposition (PBM, Choledochal
cysts)• Intrahepatic biliary stones• PSC
![Page 47: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/47.jpg)
CholangiocarcinomaDiagnosis and Initial Workup
• Jaundice• Weight loss, anorexia, abdominal pain, fever
• US – bile duct dilatation• 3-phase CT• MRCP/MRI• ERCP with Brush biopsy• Percutaneous Cholangiography with Internal
Stent and Brush Biopsy
![Page 48: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/48.jpg)
MRCP: Cholangiocarcinoma at the Bifurcation
Klatskin tumour - Cholangiocarcinoma of junction of right & left hepatic ducts
![Page 49: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/49.jpg)
ERCP: Distal CBD Cancer
![Page 50: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/50.jpg)
Surgical Removal – only 25%resectable at the time of
diagnosis• Node Dissection in Bile
Duct Excision• Roux-en-Y
Hepaticojejunostomy
![Page 51: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/51.jpg)
Cholangiocarcinoma
Palliative therapy :•Stent•Chemotherapy +/- Radiation Therapy•Survival with surgery and chemo/radiation is 24 to 36 months•With chemotherapy / radiation alone survival is 12 to 18 months•Liver transplantation – 80% 5-y survival rate•In selected patients who complete chemo-radiation protocol
![Page 52: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/52.jpg)
Gallbladder Cancer
• 6th decade• 1:3, Male:Female• Highest prevalence in Israel, Mexico,
Chile, Japan, and Native American women.
• Risk Factors: gallstones, porcelain gallbladder, polyps, Salmonella typhi carrier state, some drugs
![Page 53: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/53.jpg)
Gall Bladder Cancer
• Uncommonly diagnosed preoperatively• >80% with gallstones• Clinical manifestation from abdominal pain to
unexplained weight loss and jaundice• Palpable RUQ mass• Jaundice suggests local extention with ductal
obstruction• DS: US, EUS, CT
![Page 54: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/54.jpg)
Gall Bladder Cancer
• Discovered on pathology after a routine cholecystectomy (1-2%)
• If negative for metastasis: – Radical cholecystectomy with nodal dissection,
central hepatectomy, w or w/o bile duct excision– Excise port sites– Followed by Chemo/Radiation
• 5 year survival = 60%
![Page 55: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/55.jpg)
Gallbladder Cancer
• Cholecystectomy should not be offered for all patients with stones for fear of cancer
• Cholecystectomy should be considered for calcified GB and for growths (adenomyoma, polyps > 15 mm)
![Page 56: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/56.jpg)
Pancreatic cancer
• Pancreatic cancer is the most common malignant cause, followed by cancers of the gallbladder, bile duct, liver, and large intestine.
![Page 57: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/57.jpg)
Metastasis • 1st category involves local extension into the hilum by a tumor
arising in an adjacent structure, such as the gallbladder, cholangio CA
• The 2nd - includes metastases from a distant primary site, most often from solid tumors, such as carcinoma of the breast, colon, ovaries or lymphoma, melanoma
• Mechanical cholestasis caused by the stricture, mostly of the common hepatic or common bile duct Patients have severe jaundice and associated symptoms such as
pruritis, recurrent cholangitis and malaise.
![Page 58: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/58.jpg)
Metastasis
![Page 59: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/59.jpg)
Biliary disease
• Gallstones • Congenital anomalies• Extrinsic compression of the bile ducts
• Hepatobiliary parasitism• Noncancerous strictures
![Page 60: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/60.jpg)
Hepatobiliary parasitism
• Pyogenic cholangitis &hepatic abscess, ductal stones, biliary obstruction
• Clonorchis sinensis, Opisthorchis viverrini, O. felineus, Fasciola hepatica
• Ascaris lumbricoides, Echinococcus spp.
![Page 61: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/61.jpg)
Clinical manifestation of hydatid cyst
• Most patients with hepatic uncomplicated hydatid cyst are asymptomatic
Possible symptoms and signs are: RUQ pain , epigastric pain , fever , fatigue , nausea and dyspepsia ,hepatomegaly and abdominal mass
Complications: Superinfection of hydatid cysts Rupture to adjacent structures (peritoneal spillage, cholangitis, pancreatitis, anaphylaxis) Rare – portal HTN, hepatic vein thrombosis, secondary biliary cirrhosis
![Page 62: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/62.jpg)
Diagnosis History of exposure
Chest and abdominal X-ray
Ultrasound (diagnostic method of choice)
CT (better information about location, depth , mandatory before planning operation)
MRI (for NS, venous system and biliary complications )
Serology (positive – confirms infection, negative test does not exclude)
![Page 63: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/63.jpg)
Gharbi’s US classification Type I - Pure fluid collection Type II - Fluid collection with a detached membrane Type III - Fluid collection with multiple septa and or daughter cysts Type IV - Hyperechoic with high internal echoes Type V - Cysts with reflecting, calcified walls
![Page 64: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/64.jpg)
CT
![Page 65: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/65.jpg)
ERCP
![Page 67: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/67.jpg)
Treatment of hepatic hydatid cyst
The treatment of hepatic hydatid cysts is strongly indicated in order to prevent cyst complications
The therapeutic options are: 1. Surgical intervention – remains the
cornerstone of radical treatment 2. Percutaneous drainage 3. Drug therapy
![Page 68: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/68.jpg)
Surgical optionsOpen surgical techniques Radical removal of pericystic membrane and parasitic
content Marsupialization (partial cysto-pericystectomy)
Contraindications: severe comorbidity Complications: biliary fistula, cyst infection, pleural
effusion, peritonitis, abscess, anaphylactic shock Laparoscopic surgery Contraindications: Deep intraparenchimal cysts > 3 cysts, with thick calcified wall Complications: intra-abdominal seeding due to
pneumoperitoneum
![Page 69: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/69.jpg)
Paliative procedures PAIR - puncture-aspiration-injection-reaspiration Indicated for type I , II and III cysts Inoperable patients, pregnant women Multiple disseminated cysts Contraindications: IV, V types of cysts, ruptured cysts into biliary tree or peritoneum ERCP – Naso-biliary drainage – biliary endoprosthesis Combined therapy with albendazole is an effective and safe
alternative to surgery for uncomplicated hydatid cysts (Khuroo et al, 1998)
![Page 70: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/70.jpg)
Indications for drug therapy:
WHO Guidelines 1996 Inoperable primary liver or lung echinococcosis Multiple echinococcal multiorgan and peritoneal
cystsPreoperative or pre-drainage (at least 4 days
before surgery and 1 m (ABZ) or 3 m (MBZ) after)Poor patient status
Contraindications:Large cysts that are at risk of rupture Pregnancy ,chronic liver disease or depressed BM
![Page 71: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/71.jpg)
Biliary disease
• Gallstones • Congenital anomalies• Extrinsic compression of the bile ducts• Hepatobiliary parasitism
• Noncancerous strictures
![Page 72: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/72.jpg)
Biliary Stricture – Non Cancerous Causes
Noncancerous causes of bile duct stricture include:•Injury to the bile ducts during surgery for gallbladder removal •Pancreatitis (inflammation of the pancreas)•Primary sclerosing cholangitis • Gallstones (benign CBD stricture, papillary stenosis
•Blunt trauma to the abdomen
![Page 73: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/73.jpg)
Primary Sclerosing Cholangitis
• Chronic cholestatic biliary disease characterized by non-suppurative inflammation and fibrosis of the biliary ductal system
• Cause is unknown but is associated with autoimmune inflammatory diseases, such as chronic ulcerative colitis and Crohn’s colitis, and rare conditions, such as Riedel thyroiditis and retroperitoneal fibrosis
• Most patients present with fatigue and pruritus and, occasionally, jaundice
![Page 74: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/74.jpg)
PSC
•Natural history is variable but involves progressive destruction of the bile ducts, leading to cirrhosis and liver failure
•Clinical features of cholangitis (ie, fever, right upper quadrant pain, jaundice) are uncommon unless the biliary system has been instrumented.
![Page 75: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/75.jpg)
PSC
![Page 76: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/76.jpg)
PSCMedical Care•Chronic progressive disease with no curative medical therapy•Goals of medical management are to treat the symptoms and to prevent or treat the known complications•Liver transplantation is the only effective therapy and is indicated in end-stage liver disease.
Surgical Care•Indications for liver transplantation include variceal bleed or portal gastropathy, intractable ascites, recurrent cholangitis, progressive muscle wasting, and hepatic encephalopathy. •Recurs in 15-20% of patients after transplantation.
![Page 77: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/77.jpg)
Primary Biliary Cirrhosis
•Progressive cholestatic biliary disease that presents with fatigue and itching or asymptomatic elevation of the alkaline phosphatase.
• Jaundice develops with progressive destruction of bile ductules that eventually leads to liver cirrhosis and hepatic failure.
•Autoimmune illness has a familial predisposition
![Page 78: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/78.jpg)
PBC
Antimitochondrial antibodies )AMA( are present in 95% of patients
Goals of treatment are to slow the progression rate of the disease and to alleviate the symptoms )eg, pruritus, osteoporosis, sicca syndrome(
Liver transplantation appears to be the only life-saving procedure.
![Page 79: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/79.jpg)
ERCP
Endoscopic retrogradecholangiopancreatography (ERCP) •Endoscopic tube is placed into the patient’s mouth, through the stomach, and into the duodenal portion of the small intestine. •Contrast is introduced into the biliary tract through the endoscope, in a retrograde manner. •X-rays taken
![Page 80: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/80.jpg)
ERCP• ספינקטרוטומיה
• הוצאת אבנים )בלון, בסקט(, ריסוק אבנים• הכנסת סטנטם
![Page 81: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/81.jpg)
PTC הזרקת חומר ניגוד דרך עור לדרכי מרה
התוך כבדיים תחת סונר והדמיה ברנטגן
![Page 82: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/82.jpg)
PCC
• PerCutaneous Cholecystostomy• במקרים קשים בהם ניתוח עלול לסכן את החולה –
ניקוז מרה בשיטה מלעורית
![Page 83: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/83.jpg)
Indications For Biliary Stenting
Indications for stent insertion include:•Ampullary Stenosis•Bile duct injury•Benign or malignant biliary obstruction•Prevention of obstruction where stone
extraction is not possible at that time•Pancreatic duct strictures, stones and
sphincter of Oddi dysfunction
![Page 84: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/84.jpg)
Stent Placement -Endoscopic Approach
• A catheter is inserted through the endoscope into the ostium of the common bile duct.
• While maintaining the endoscope position in the duodenum, a wire is inserted through the catheter into the bile duct.
• The stent delivery system is then inserted over the wire to the site of obstruction, where the stent is deployed.
![Page 85: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/85.jpg)
Stent Placement – Endoscopic Approach
Success rate of ERCP 90-95%Complication rate of approximately 3-5%. Complications:• Pancreatitis• Bleeding• Perforation• Infection• Cardiopulmonary depression from conscious sedation.
![Page 86: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/86.jpg)
Biliary Stent - Percutaneous transhepatic approach PTC
For biliary stent placement using a percutaneous approach:•A fine needle is inserted between the 4th and 5th rib on the patient’s right side•The puncture is through the liver•The needle is inserted into an intrahepatic duct under image guidance.
Photo on file at Medtronic
![Page 87: Biliary Tract Disease](https://reader035.vdocuments.us/reader035/viewer/2022081414/56813198550346895d980bac/html5/thumbnails/87.jpg)
Biliary Stent - Percutaneous Approach
Success rate 95% when ducts are dilated• 5-10% rate of major complications which include:•Sepsis•Bile leak•Intraperitoneal haemorrhage, Haemobilia•Hepatic and perihepatic abscess, Pneumothorax•Skin infection and granuloma at the catheter entry site
• Contraindicated in patients with bleeding diatheses and significant ascites.